Sanara Medtech Inc. last reported quarterly results on Aug 11, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $28.1 million (+9.0% year over year) and diluted EPS of -$0.05. It usually reports 23–43 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 11, 2026.
Results for Q3 FY2026, the quarter ending around Sep 30, 2026. Expected on a Wednesday. Based on last year's release for the same quarter on Nov 12, 2025. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 23–43 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 11, 2026
42 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
28
+9.0%
|
-0
+77.5%
|
-0.05
+78.3%
|
|
May 11, 2026
41 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
28
+18.6%
|
0
+113.0%
|
0.05
+112.2%
|
|
Jan 23, 2026
23 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
28
+4.7%
|
-2
-4.6%
|
-0.21
-14.7%
|
|
Nov 12, 2025
43 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
26
+21.5%
|
-30
-964.2%
|
-3.40
-900.0%
|
|
Aug 13, 2025
44 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
26
+28.0%
|
-2
+42.5%
|
-0.23
+43.9%
|
|
May 14, 2025
44 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
23
+26.4%
|
-4
-99.9%
|
-0.41
-95.2%
|
|
Jan 21, 2025
21 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
26
+48.7%
|
-2
-548.7%
|
-0.18
-537.2%
|
|
Nov 12, 2024
43 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
22
+35.2%
|
-3
-169.5%
|
-0.34
-161.5%
|
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- SMTI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- TX
- Headquarters
- Fort Worth, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 714256
- Former names
- WOUND MANAGEMENT TECHNOLOGIES, INC. (until Apr 3, 2019); MB SOFTWARE CORP (until Jun 10, 2008); INAV TRAVEL CORPORATION (until May 3, 1996)
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.